Literature DB >> 14518107

Report on active surveillance for adverse events following the use of drug co-administrations in the global programme to eliminate lymphatic filariasis.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14518107

Source DB:  PubMed          Journal:  Wkly Epidemiol Rec        ISSN: 0049-8114


× No keyword cloud information.
  6 in total

Review 1.  Community views on mass drug administration for filariasis: a qualitative evidence synthesis.

Authors:  Melissa Taylor; Rebecca Thomas; Sandy Oliver; Paul Garner
Journal:  Cochrane Database Syst Rev       Date:  2022-02-17

2.  The Mectizan Donation Program - highlights from 2005.

Authors:  Mary M Alleman; Nana A Y Twum-Danso; Björn I Thylefors
Journal:  Filaria J       Date:  2006-09-27

Review 3.  Efficacy and safety of co-administered ivermectin plus albendazole for treating soil-transmitted helminths: A systematic review, meta-analysis and individual patient data analysis.

Authors:  Marta S Palmeirim; Eveline Hürlimann; Stefanie Knopp; Benjamin Speich; Vicente Belizario; Serene A Joseph; Michel Vaillant; Piero Olliaro; Jennifer Keiser
Journal:  PLoS Negl Trop Dis       Date:  2018-04-27

4.  Triple co-administration of ivermectin, albendazole and praziquantel in zanzibar: a safety study.

Authors:  Khalfan A Mohammed; Hamad J Haji; Albis-Francesco Gabrielli; Likezo Mubila; Gautam Biswas; Lester Chitsulo; Mark H Bradley; Dirk Engels; Lorenzo Savioli; David H Molyneux
Journal:  PLoS Negl Trop Dis       Date:  2008-01-23

Review 5.  Controlling soil-transmitted helminthiasis in pre-school-age children through preventive chemotherapy.

Authors:  Marco Albonico; Henrietta Allen; Lester Chitsulo; Dirk Engels; Albis-Francesco Gabrielli; Lorenzo Savioli
Journal:  PLoS Negl Trop Dis       Date:  2008-03-26

6.  Safety and Tolerability of Mass Diethylcarbamazine and Albendazole Administration for the Elimination of Lymphatic Filariasis in Kenya: An Active Surveillance Study.

Authors:  Christabel Khaemba; Abbie Barry; Wyckliff P Omondi; Kefa Bota; Sultani Matendechero; Cecilia Wandera; Fred Siyoi; Elvis Kirui; Margaret Oluka; Pamela Nambwa; Parthasarathi Gurumurthy; Sammy M Njenga; Anastacia Guantai; Eleni Aklillu
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.